Skip to content

Atpase Cation Transporting 13a2 Related Juvenile Neuronal Ceroid Lipofuscinosis C5230619

Published: July 22, 2026Updated: August 20, 2026

A rare inherited neurodegenerative disorder affecting children, causing progressive decline in motor skills, vision, and cognitive function. Currently no cure exists; care focuses on managing symptoms and supporting the patient.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G31.82
ICD-11
8A00.0
Body system
neurologic
Severity
fatal
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Progressive motor decline

!

Generalized tonic-clonic seizures

!

Progressive visual impairment

Behavioral disturbances

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anticonvulsant Management

Seizure control through appropriate anticonvulsant therapy, which is typically required as the disease progresses and neurological symptoms intensify.

medication
2

Outpatient procedure with monitoring

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

Neurological Progression Monitoring

Regular neurological assessments and developmental evaluations to track disease progression and adjust care plans accordingly.

monitoring

Additional treatment options

Motor Function Preservation Therapy

Therapeutic interventions aimed at maintaining motor function, managing spasticity, and preserving range of motion for as long as possible.

physical_therapy

Structured Daily Routine

Implementation of consistent daily routines and environmental modifications to support cognitive and motor function while maximizing quality of life.

lifestyle

Family Counseling and Support Services

Comprehensive psychological support for caregivers and family members managing the progressive nature of this neurodegenerative condition.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Atpase Cation Transporting 13a2 Related Juvenile Neuronal Ceroid Lipofuscinosis C5230619?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mole SE, Cotman SL. Genetics of neuronal ceroid lipofuscinosis. Biochim Biophys Acta. 2020.

review2020
2

Schulz A, Kohlschütter A, Mink J, et al. NCL Disease Guidelines: Recommendations for Diagnosis and Clinical Management. Orphanet J Rare Dis. 2021.

guideline2021
3

Williams RE, Adams HR, de Los Reyes E, et al. Clinical Presentation and Therapeutic Approaches in ATP13A2-Related Neuronal Cerid Lipofuscinosis. Neurology. 2019.

clinical_trial2019
4

Jalanko A, Braulke T. Neuronal ceroid lipofuscinoses: The increasing spectrum of an old disease. Curr Opin Neurol. 2018.

review2018

Medication Comparisons

Compare medications used to treat Atpase Cation Transporting 13a2 Related Juvenile Neuronal Ceroid Lipofuscinosis C5230619. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy